AWMF Clinical Practice Guideline

An organization that is a member of the AWMF

AWMF S1 guideline representing expert recommendations developed through informal consensus.

AWMF S2e guideline based on systematic literature search and evaluation.

AWMF S2k guideline based on structured consensus by a representative panel.

AWMF S3 guideline based on systematic evidence review and structured consensus by a representative panel.

A structured assessment of the certainty of evidence for a specific outcome.

A structured assessment of the quality of guidelines using the AGREE II instrument.

A structured assessment of the certainty of evidence using AMSTAR 2.

Structured assessment of risk of bias using Cochrane RoB tool.

A structured assessment of the certainty of evidence for a specific outcome, including GRADE rating.

A structured assessment of the certainty of evidence for a specific outcome, including Oxford 2011 rating.

Structured assessment of risk of bias using ROBIS (Risk of Bias in Systematic Reviews).

Clinical Practice Guideline

Attachment to a Clinical Practice Guideline

A person that authored a guideline.

The role of the author of the guideline.

Represents evidence supporting a specific outcome within a body of clinical or scientific evidence.

Clinical Practice Guideline Recommendation

A structured assessment of the evidence and consensus that underpins a recommendation.

A structured assessment of the evidence and consensus that underpins a recommendation, including AWMF rating.

A structured assessment of the evidence and consensus that underpins a recommendation, including GRADE rating.

This extension provides additional contact details for individuals or organizations associated with an artifact (e.g., a clinical document, guideline, or other composition).

This extension allows for the specification of the language(s) the author contributed to a section in a FHIR Composition.

This extension allows for the indication of the period during which the guideline is open for consultation.

This extension allows for the indication of the date when the guideline was first published.

This extension allows for the indication of the role of the author of the guideline.

This extension allows for the indication of the date when the guideline is planned to be completed.

This extensions allows for the indication of the date when the guideline was published.

This extension allows for the indication of the status of a recommendation in the context of an updated guideline version

This extensions allows for the indication of the date the guideline project was registered.

This extension defines a classification for the 'relatesTo' relationship using a CodeableConcept.

This extension defines a label for the 'relatesTo' relationship using a CodeableConcept.

This extension allows for the assignment of a specific code to a section within a Composition resource. The code provides a standardized way to categorize or identify the content of the section, enabling better organization, searchability, and interoperability of clinical documents or other structured artifacts.

This extension allows for the indication of the target audience for the section

This extension allows for the indication of keywords associated with the section

This extension allows for the indication of the Language of the Section.

This extension allows for the indication of the date when the guideline was submitted to the system.

ValueSet encompassing all domains from the AGREE II instrument.

ValueSet encompassing all overall confidence ratings from the AMSTAR 2 critical appraisal tool.

ValueSet listing values representing guideline classes according to the AWMF.

ValueSet listing values to define the guideline status according to the AWMF.

ValueSet listing various body system conditions

ValueSet listing levels of care.

ValueSet listing stages of care from prevention to rehabilitation.

ValueSet listing different clinical application types

ValueSet listing types of content that can be part of a guideline or recommendation.

ValueSet listing types of dissemination websites

ValueSet listing types of patient encounters based on hospitalization status.

Value set of commonly used evidence rating and appraisal systems

ValueSet listing roles that a author can have in a guideline.

ValueSet listing contact points relevant to guidelines, such as registrants, coordinators, and main contacts.

ValueSet listing different guideline release types

ValueSet listing values to use to define guideline sections

ValueSet listing codes representing intended audiences for a section

ValueSet listing values to define the level of consensus for a recommendation.

ValueSet encompassing all levels from the OCEBM 2011 Levels of Evidence.

ValueSet encompassing all risk of bias judgment values from the ROBIS tool.

ValueSet encompassing all risk of bias domains from the ROBIS tool.

ValueSet defining if the alternatives are acceptable for the target population and its implementors?

ValueSet listing values to represent the summary of the most important benefits and harms

Codes from EvidenceCertaintyRating related to certainty of evidence

ValueSet listing codes from EvidenceCertaintyRating related to degree of concern

ValueSet listing values to represent how the different alternatives affect equity

ValueSet listing values to reprensent how feasible will it be to implement the different alternatives and if there are any issues

ValueSet listing typical patient preferences and values as well as common issues or expected variability

ValueSet listing values to indicate if there are issues related to costs or resource use.

ValueSet of strength of recommendations as defined in AWMF guideline methodology.

ValueSet listing different synthesis Types of recommendations

ValueSet listing different tags to use for recommendations

ValueSet representing the version-related status of a recommendation in a new guideline version

ValueSet listing types of remarks that can be associated with guidelines, including restrictions, warnings, and additional notes.

ValueSet listing values to represent the overall judgment of risk of bias assessed by the RoB2 tool for evaluating risk of bias for randomized trials.

ValueSet listing patient population categories for guidelines, such as adults and children/adolescents.

CodeSystem representing the domains assessed by the AGREE II instrument for evaluating the quality of clinical practice guidelines.

CodeSystem representing the overall confidence ratings from the AMSTAR 2 critical appraisal tool.

As part of the project planning for the creation or updating of a guideline, a decision should be made at an early stage about the planned level classification ("S classification") according to the AWMF's system of rules (1-3). The S-classification scheme of the AWMF differentiates between the classes S1 treatment recommendation as well as S2e, S2k and S3 guideline. The "S" stands for the extent of the applied systematic approach in the development process of a guideline. Each class thus stands for a specific methodological concept that must be presented in a way that is comprehensible to the users. The choice of class is based on the question of how much effort is appropriate and feasible. The need for legitimacy for the implementation of the guideline (convincing the target group) must be taken into account. When choosing a higher S-classification in the context of updating a guideline, the adaptation to the corresponding methodology has to be considered.

CodeSystem representing the guideline status according to the AWMF.

CodeSystem representing various body system conditions.

CodeSystem defining different care settings, including levels of care, healthcare services, and treatment contexts.

CodeSystem defining different clinical application types

CodeSystem defining types of contact points for a guideline

CodeSystem for identifying evidence rating and appraisal frameworks used in systematic reviews, guideline development, and clinical decision support.

CodeSystem defining GRADE Evidence to Decision (EtD) Framework Certainty Ratings

CodeSystem defining values to represent the GRADE Evidence to Decision (EtD) Framework Certainty Type

CodeSystem defining roles for the author of the guideline.

CodeSystem defining different guideline release types

Sections of a guideline, describing various aspects such as its intention, target patient group, care setting, and other relevant contextual information.

CodeSystem defining possible intended audiences for a section

CodeSystem defining the values representing the level of consensus for a recommendation.

CodeSystem defining values to classify medical subjects into different categories.

CodeSystem representing the Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence.

CodeSystem representing the judgment of risk of bias assessed by the ROBIS tool for evaluating risk of bias in systematic reviews.

CodeSystem representing the domains assessed by the ROBIS tool for evaluating risk of bias in systematic reviews.

CodeSystem defining the grading of recommendations according to German guideline methodology as used in AWMF S3 guidelines.

CodeSystem defining values representing the synthesis type of a recommendation

CodeSystem defining codes to represent tags for recommendations

CodeSystem defining values indicating how a recommendation relates to a new version of the guideline

CodeSystem defining types of related artifacts that can be part of a guideline.

CodeSystem defining different types of remarks that can be associated with guidelines, including restrictions, warnings, and additional notes.

CodeSystem representing the overall judgment of risk of bias assessed by the RoB2 tool for evaluating risk of bias for randomized trials.

CodeSystem defining the intended patient population for whom the guideline is applicable.

CodeSystem representing different codes of interest for the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)

An example of an AWMF guideline.

An example of an AWMF S1 guideline.

An example of an AWMF S2e guideline.

An example of an AWMF S2k guideline.

An example of an AWMF S3 guideline.

An example of an AWMF member organization.

Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)

Certainty of evidence rating for the impact of Multiplex-PCR-Diagnostik on antibiotic days

Certainty of evidence rating for the impact of Multiplex-PCR-Diagnostik on mortality

Certainty of evidence rating for the impact of Multiplex-PCR-Diagnostik on time to deescalation

Concept map from concepts from standardized vocabularies that are not labelled as 'standard' in Athena – OHDSI Vocabularies Repository to Concept IDs from 'standard' concepts

Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin e.V. (DGAI)

Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e.V. (DGP)

Deutsche Gesellschaft für Chirurgie e.V. (DGCH)

Deutsche Gesellschaft für Hygiene und Mikrobiologie e.V. (DGHM)

Deutsche Gesellschaft für Infektiologie e.V. (DGI)

Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin e.V. (DGIIN)

Deutsche Gesellschaft für Innere Medizin e.V. (DGIM)

Deutsche Röntgengesellschaft, Gesellschaft für Medizinische Radiologie e.V. (DRG)

Deutsche Sepsis-Gesellschaft e.V. (DSG)

Evidence for the impact of Multiplex-PCR-Diagnostik on antibiotic days

Evidence for the impact of Multiplex-PCR-Diagnostik on mortality

Evidence for the impact of Multiplex-PCR-Diagnostik on time to deescalation

Foliensatz Leitlinie 020-013

Gesellschaft für Virologie e.V. (GfV)

An example of a guideline attachment.

An example of a guideline author.

An example of a guideline author role.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

An example of a guideline.

Fails because the contributing author points to a Practitioner instead of an Organization.

Passes because the leading author points to an Organization.

Fails because the leading author points to a Practitioner instead of an Organization.

Wie wird eine HAP klinisch diagnostiziert und welche Differenzialdiagnosen sind zu beachten?

Wie wird eine HAP klinisch diagnostiziert und welche Differenzialdiagnosen sind zu beachten?

Wie wird eine HAP klinisch diagnostiziert und welche Differenzialdiagnosen sind zu beachten?

Implementierungshilfe Leitlinie 020-013

Jessica Rademacher

Jessica Rademacher for DGP in the context of 020-013

Kurzfassung Leitlinie 020-013

Langfassung Leitlinie 020-013

Leitlinienreport Leitlinie 020-013

Wird der Einsatz von Multiplex-PCR im Rahmen der mikrobiologischen Diagnostik bei Patienten mit Verdacht auf nosokomiale Pneumonie empfohlen?

Netzwerk chronisch pulmonale Aspergillose (CPAnet)

Outcome Antibiotic Days

Outcome Mortality

Outcome Time to Deescalation

Paul-Ehrlich-Gesellschaft für Infektionstherapie e.V. (PEG)

Patienteninformation Leitlinie 020-013

An example of a recommendation.

Justification for Recommendation HAP Diagnose A

Justification for Recommendation HAP Diagnose B

Justification for Recommendation Multiplex-PCR-Diagnostik

Robert Koch-Institut

S3-Leitlinie zur Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie